AzTrials
AzTrials

Artificial IntelligenceNCT05829590

AI-assisted Colonoscopy Report System In Improving Reporting Quality

A study testing Artificial intelligence assistant system in people with Artificial Intelligence and Colonoscopy, run by Renmin Hospital of Wuhan University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In this study, the investigators proposed a prospective study about the effectiveness of speech and image recognition-based system in improving reporting quality during colonoscopy for colonoscopy report quality in endoscopists. The participants would be divided into two groups. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Artificial Intelligence, Colonoscopy
What is being tested?
Artificial intelligence assistant system
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteChina
Study dates
15 May 2023to 31 Jul 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients:
  • Male or female ≥18 years old;
  • Able to read, understand and sign an informed consent;
  • The investigator believes that the subjects can understand the process of the clinical study, are willing and able to complete all study procedures and follow-up visits, and cooperate with the study procedures;
  • Patients requiring colonoscopy.
  • Doctors:
  • Males or females who are over 18 years old;
  • After qualified medical education and obtaining the Physician's Practice License.

Who cannot join

  • Patients:
  • Have drug or alcohol abuse or mental disorder in the last 5 years;
  • Pregnant or lactating women;
  • Patients with known multiple polyp syndrome;
  • patients with known inflammatory bowel disease;
  • known intestinal stenosis or space-occupying tumor;
Show all 13Show fewer
  • known colon obstruction or perforation;
  • patients with a history of colorectal surgery;
  • Patients with a previous history of allergy to pre-used spasmolysis;
  • Unable to perform biopsy due to coagulation disorders or oral anticoagulants;
  • High-risk diseases or other special conditions that the investigator considers the subject unsuitable for participation in the clinical trial.
  • Doctors:
  • 1. The researcher believes that the subjects are not suitable for participating in clinical trials.

Trial locations and contacts

1 site in 1 country.

Honggang Yu, MD contact

13871281899

yuhonggang1969@163.com

China1 site
  • Renmin Hospital of Wuhan Univercity

    Wuhan, Hubei, 430060

Other trials in China

About this study

Official title: Speech and Image Recognition Based System in Improving Reporting Quality During Colonoscopy

In this study, the investigators proposed a prospective study about the effectiveness of speech and image recognition-based system in improving reporting quality during colonoscopy for colonoscopy report quality in endoscopists. The participants would be divided into two groups. For the collected colonoscopy videos, group A would record their observations with the assistance of the artificial intelligence system. The artificial intelligence assistant system can automatically capture bowel segment images and prompt abnormal lesions. Group B would complete the endoscopy report without special prompts. After a period of washout period, the two groups switched, that is, group A without AI assistance and group B with AI assistance to complete the colonoscopy report. Then, the completeness of the colonoscopy report, the completeness of capturing anatomical landmarks and detected lesions, the completeness of structured description, the accuracy of lesion reporting, the time for reporting and the satisfaction with the reporting system are compared with or without AI assistance.

Being tested
Artificial intelligence assistant system

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Artificial intelligence assistant systemDiagnostic test

    The artificial intelligence assistant system can automatically capture bowel segment images and prompt abnormal lesions based on speech recognition and deep learning.

Study groups in NCT05829590
Study groupRoleWhat they receive
with Artificial intelligence assistant systemExperimentalEndoscopists would complete the colonoscopy report with the assistance of the artificial intelligence system.
Receives: Diagnostic Test: Artificial intelligence assistant system
without Artificial intelligence assistant systemNo interventionEndoscopists would complete the colonoscopy report without special prompts.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The integrity of colonoscopy report

    Report integrity with or without AI-assisted. Calculation method = number of information recorded / total number of information need to record x 100%

    Measured: One month

Secondary outcomes (1)
  1. The integrity of capturing anatomical landmarks

    The integrity in captured bowel landmrak images with or without AI-assisted. Calculation method = number of anatomical landmarks in captured images / total number of anatomical landmarks x 100%

    Measured: One month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Apr 2023
  2. Study start15 May 2023 (estimated)
  3. Primary completion15 Jun 2023 (estimated)
  4. Study completion31 Jul 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Device feasibility
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
10 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05829590
Sponsor's protocol ID
EA-23-002
Status last verified
Mar 2023
First submitted
2 Apr 2023
Last updated
25 Apr 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Artificial intelligence assistant system in people with Artificial Intelligence and Colonoscopy, run by Renmin Hospital of Wuhan University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Honggang Yu, MD (13871281899, yuhonggang1969@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The integrity of colonoscopy report (time frame: One month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT05829590 | AzTrials